Intrexon | XON - Passivo Circulante





Passivo Circulante Alterar Data
Agenus USD 249.24M 74.25M 2026-03
Alaunos Therapeutics USD 595K 218K 2026-03
Amgen USD 24.96B 534M 2026-03
Anika Therapeutics USD 20.97M 942K 2026-03
Arrowhead Research USD 295.22M 52.2M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Heron Therapeutics USD 90.52M 5.58M 2026-03
Incyte USD 1.49B 25.52M 2026-03
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Ligand Pharmaceuticals USD 40.67M 3.22M 2026-03
MacroGenics USD 95.94M 52.82M 2026-03
MannKind USD 134.56M 36.47M 2026-03
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.37B 4.1B 2026-03
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Veracyte USD 56.11M 3.82M 2026-03
Xencor USD 73.46M 22.45M 2026-03